{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:27:54Z","timestamp":1773980874667,"version":"3.50.1"},"reference-count":33,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background According to the European Pharmacopoeia, multidose containers for eye drops must either contain antimicrobial agents, preservatives, or be fitted with filters or non-return valves to prevent microbial contamination after opening. Vials for single-day use do not have filters or non-return valves. The aim of this study is to demonstrate the safety of reclosable vials (ophtioles) containing unpreserved autologous serum eye drops (ASEDs) by evaluating their sterility during single-day use.<\/jats:p><jats:p>\n          Material and Methods Two types of reclosable ophtioles were evaluated, one with a screw cap (Meise System, Heinz Meise GmbH, Schalksm\u00fchle, Germany) and the other one with a plug cap (COL System, BIOMED DEVICE S.\u200aR.\u200aL., Modena, Italy). Drop application over 12 hours was simulated in the laboratory following the manufacturer\u02bcs instructions. For the Meise System, drops were applied at 2-hour intervals, while for the COL System, drops were applied at 1-hour intervals. Each application involved inoculating a chocolate-agar PolyViteX plate (PolyViteX, bioM\u00e9rieux SA, Marcy-l\u02bc\u00c9toile, France) with two drops spaced apart on the same plate and then incubating the plate. After 24 hours, a final inoculation was performed to check for sterility, and the plates were scored after 24 and 48 hours of incubation.<\/jats:p><jats:p>\n          Results In the Meise System test series, 12 vials were tested, providing 192 measurements over 12 hours with a 2-hour application interval. With the COL System, 16 vials were tested, resulting in 448 measurements with a 1-hour application interval over 12 hours. Neither the Meise nor the COL System showed contamination of any application after 24 hours of incubation. After 48 hours of incubation, two vials of the Meise System showed a contamination in one measurement, but subsequent applications were sterile again. In the COL System, nine measurements in seven vials were positive. In three of these vials, the last application at 24 hours showed contamination after 48 hours of incubation, where no further drops were applied.<\/jats:p><jats:p>\n          Conclusion The study confirms the sterility of ASEDs in two reclosable types of ophtiole systems during single-day use in laboratory-simulated conditions within 12 hours of application and 24 hours of incubation time. This is consistent with our several years of clinical experience of the absence of ocular infections caused by the use of ASEDs in the described ophtioles.<\/jats:p>","DOI":"10.1055\/a-2496-7289","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T22:40:16Z","timestamp":1744843216000},"page":"304-309","source":"Crossref","is-referenced-by-count":3,"title":["Sterility Assessment of Reclosable Ophtioles with Unpreserved Autologous Serum during Single-Day Use"],"prefix":"10.1055","volume":"242","author":[{"given":"Frank","family":"Blaser","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Meneau","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg","family":"Wiedler","sequence":"additional","affiliation":[{"name":"Blutspendezentrum Z\u00fcrich, Schweizerisches Rotes Kreuz, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Lamprecht","sequence":"additional","affiliation":[{"name":"Blutspendezentrum Z\u00fcrich, Schweizerisches Rotes Kreuz, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5431-4991","authenticated-orcid":false,"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Zweifel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Perschak","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-1805","authenticated-orcid":false,"given":"Maximilian Robert Justus","family":"Wiest","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Fierz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-4766","authenticated-orcid":false,"given":"Sadiq","family":"Said","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-9136","authenticated-orcid":false,"given":"Anahita","family":"Bajka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"R A Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"R I Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sj\u00f6gren\u02bcs syndrome","volume":"83","author":"K Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-012-0175-y","article-title":"Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis","volume":"56","author":"K M Kim","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ico.0000000000000271","article-title":"Long-term use of autologous serum 50\u200a% eye drops for the treatment of dry eye disease","volume":"33","author":"M Hussain","year":"2014","journal-title":"Cornea"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"521315","DOI":"10.1155\/2013\/521315","article-title":"Topical 100\u200a% serum eye drops for treating corneal epithelial defect after ocular surgery","volume":"2013","author":"K Lekhanont","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref7","first-page":"U330","article-title":"The efficacy of autologous serum eye drops for Keratoconjunctivitis Sicca \u2013 A prospective study","volume":"45","author":"T Kojima","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"G Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/02713683.2013.824987","article-title":"The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment","volume":"39","author":"K Jirsova","year":"2014","journal-title":"Curr Eye Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/15569527.2016.1209770","article-title":"Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease","volume":"36","author":"A A Azari","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1133381","DOI":"10.3389\/fmed.2023.1133381","article-title":"Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease","volume":"10","author":"C Tappeiner","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8906","DOI":"10.1038\/s41598-022-12879-x","article-title":"Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease","volume":"12","author":"C Metheetrairut","year":"2022","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s00347-003-0979-8","article-title":"[Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation]","volume":"101","author":"P Herminghaus","year":"2004","journal-title":"Ophthalmologe"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ophtha.2019.08.018","article-title":"Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology","volume":"127","author":"R M Shtein","year":"2020","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1172345","DOI":"10.3389\/fcimb.2023.1172345","article-title":"Disturbances in the ocular surface microbiome by perioperative antimicrobial eye drops","volume":"13","author":"F Hotta","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1080\/02713683.2020.1741008","article-title":"An Environmental Control Experiment for Contamination of the Production and Storage of 20\u200a% Autologous Serum Eye Drops","volume":"45","author":"Y Yang","year":"2020","journal-title":"Curr Eye Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/ICO.0b013e3182910036","article-title":"Contamination risk of 100\u200a% autologous serum eye drops in management of ocular surface diseases","volume":"32","author":"O Thanathanee","year":"2013","journal-title":"Cornea"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jen.2018.03.007","article-title":"Effectiveness of a Novel Specimen Collection System in Reducing Blood Culture Contamination Rates","volume":"44","author":"M Bell","year":"2018","journal-title":"J Emerg Nurs"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jiac.2021.02.027","article-title":"Comparison of 0.5\u200a% chlorhexidine gluconate alcohol with 10\u200a% povidone-iodine for skin disinfection in children to prevent blood culture contamination","volume":"27","author":"N Maeda","year":"2021","journal-title":"J Infect Chemother"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bjo.2003.025528","article-title":"A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders","volume":"88","author":"R Lagnado","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/bjo.2008.144469","article-title":"Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers","volume":"92","author":"M S Kim","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhin.2005.08.009","article-title":"Contamination of single-use Minims eye drops by multiple use in clinics","volume":"62","author":"M A Qureshi","year":"2006","journal-title":"J Hosp Infect"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/eye.2009.39","article-title":"The reuse of opthalmic Minims: an unacceptable cross-infection risk?","volume":"24","author":"P Rautenbach","year":"2010","journal-title":"Eye (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e001632","DOI":"10.1136\/bmjophth-2024-001632","article-title":"Multiple use of preservative-free single dose unit dexamethasone 0.1\u200a% eye drops is safe within 24 hours","volume":"9","author":"F C Fierz","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/bjo.80.7.588","article-title":"Control of microbial contamination in unpreserved eyedrops","volume":"80","author":"G B Oldham","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/pharmaceutics16070933","article-title":"Evaluating and Managing the Microbial Contamination of Eye Drops: A Two-Phase Hospital-Based Study","volume":"16","author":"L Roquefeuil","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0211923","DOI":"10.1128\/aem.02119-23","article-title":"Eye infection risks from Pseudomonas aeruginosa via hand soap and eye drops","volume":"90","author":"A Gitter","year":"2024","journal-title":"Appl Environ Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/pharmaceutics14102176","article-title":"Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review","volume":"14","author":"K Iskandar","year":"2022","journal-title":"Pharmaceutics"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13693780701487979","article-title":"Evaluation of fungal and bacterial contaminations of patient-used ocular drops","volume":"46","author":"M Feghhi","year":"2008","journal-title":"Med Mycol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/bjo.2005.078386","article-title":"Microbial contamination of preservative free eye drops in multiple application containers","volume":"90","author":"M Q Rahman","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/ijpp.12215","article-title":"How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique","volume":"24","author":"R Sayner","year":"2016","journal-title":"Int J Pharm Pract"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ajo.2011.05.015","article-title":"A video study of drop instillation in both glaucoma and retina patients with visual impairment","volume":"152","author":"A L Hennessy","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/a-2249-0056","article-title":"A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles","volume":"241","author":"F Blaser","year":"2024","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2496-7289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T22:40:37Z","timestamp":1744843237000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2496-7289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,4,16]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2496-7289","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}